PureHealth signed a Memorandum of Understanding with the National Multiple Sclerosis Society on 24 July 2026 at Sheikh Shakhbout Medical City, launching a joint effort to improve MS care across the UAE. The MoU brings together PureHealth’s clinical network and NMSS’s advocacy expertise to boost awareness, accelerate early diagnosis and enhance treatment pathways.
Partnership aims to raise MS awareness
Multiple sclerosis is a chronic neurological condition that attacks the brain and spinal cord, often causing physical, cognitive and mobility challenges for people in early to mid‑adulthood. While the disease affects an estimated 2.9 million people worldwide, prevalence in the UAE has been climbing over the past decade, prompting calls for stronger public education.
“Multiple sclerosis continues to require greater efforts to support the early recognition of its symptoms and enable patients to access timely diagnosis and the right care,”— Leya Aldamani, Chief Sustainability Officer, PureHealth
Implementing the UAE’s first MS Treatment Guidelines
A central focus of the collaboration is the rollout of the UAE’s first MS Treatment Guidelines, which NMSS has led and published. By embedding these guidelines into clinical practice and payer systems, the partners hope to standardise diagnosis, speed access to highly effective therapies and align insurance coverage with the latest evidence.
“Meaningful progress in MS care cannot happen in silos, and people living with the condition benefit most when healthcare, advocacy and community support work hand in hand,”— Maral Alexandrian, Acting Executive Director, National Multiple Sclerosis Society
Extending support to vulnerable groups
The alliance also pledges to enhance support for vulnerable groups, including pregnant patients who face unique challenges when managing MS. By integrating specialised care protocols, the partners aim to reduce risks and improve outcomes for both mothers and their babies.
PureHealth’s role as a founding member of the National Coalition for MS further strengthens the coordinated, evidence‑based approach championed by the MoU, positioning the UAE as a regional leader in comprehensive multiple sclerosis care.
Frequently asked questions
When was the MoU between PureHealth and the National Multiple Sclerosis Society signed?
The memorandum of understanding was signed on 24 July 2026 at Sheikh Shakhbout Medical City.
What is the main goal of the PureHealth and NMSS partnership in the UAE?
The partnership aims to raise multiple sclerosis awareness, accelerate early diagnosis, and introduce the UAE’s first MS treatment guidelines to improve care across the Emirates.
How will the new MS treatment guidelines affect patients in the UAE?
Embedding the guidelines into clinical practice and payer systems will standardise diagnosis, speed access to effective therapies, and align insurance coverage with the latest evidence, leading to more consistent care.
Who are the key representatives mentioned in the PureHealth‑NMSS agreement?
Leya Aldamani, Chief Sustainability Officer of PureHealth, and Maral Alexandrian, Acting Executive Director of the National Multiple Sclerosis Society, are quoted in the announcement.
What support will the partnership provide for vulnerable MS patients, such as pregnant women?
The alliance pledges enhanced support for vulnerable groups, including specialised care protocols for pregnant patients to reduce risks and improve outcomes for mothers and babies.
